News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Dynavax Technologies Corporation Sinks on Discounted Offering, CEO Exit
May 9, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
May 9 (Reuters) - Shares of Dynavax Technologies Corp , which priced its public offering at a steep discount, fell as much as 22 percent a day after the biopharmaceutical company said its chief executive intends to step down.
Twitter
LinkedIn
Facebook
Email
Print
IPO
People
Dynavax Technologies
MORE ON THIS TOPIC
Mergers & acquisitions
Another Bidding War Breaks as Lundbeck Bids for Sleep Biotech Avadel
November 14, 2025
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
Merck Again Brings Out Big Bucks, Buys Cidara in $9.2B Antiviral Push
November 14, 2025
·
2 min read
·
Tristan Manalac
China
Recently Launched Third Arc Turns to China for Cancer T Cell Engagers
November 13, 2025
·
2 min read
·
Tristan Manalac
Drug Development
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
November 12, 2025
·
5 min read
·
Jennifer Smith-Parker